What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

16/08/2015 - 2 minutes

Encouraging facts for the European Biotech ecosystem this week! Neil Woodford’s mega Biotech fund is gathering new money to pour over the European companies. Definitely good news for the financing of companies in Europe, which still lags behind the US.

Another interesting fact is that one of the co-discoverer of CRISPRs, the biggest discovery of the century, chose to move to the German capital.

Top scientists + fresh money = definitely good news for European biotechs! 

Find out more in this week’s highlights:

It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund

Neil Woodford is a legendary British Biotech investor who opened a new mega €1.1Bn Biotech fund, named Woodford Patient Capital Trust, the biggest UK trust ever!


Emmanuelle Charpentier, co-discoverer of CRISPR-Cas9 Technology, comes to Berlin!

French, young and brilliant, Emmanuelle Charpentier will now be working as a director at the Max Planck Institute for Infection Biology in Berlin!

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!